Thu, 5 Nov
Krishna Institute Of Medical Sciences
KIMS delivered strong revenue growth led by Kondapur's rapid ramp-up, despite temporary margin compression from new oncology programs.
Summary ready
Earnings calls
Krishna Institute Of Medical Sciences concalls
Every Krishna Institute Of Medical Sciences earnings call we streamed: the live audio and our summary of what management said.
Calls
Q2 FY27: key takeaways
Call page →KIMS delivered strong revenue growth led by Kondapur's rapid ramp-up, despite temporary margin compression from new oncology programs.
Outlook
Expects 30% EBITDA margins at Kondapur and ₹1,100 Cr capex over next 18 months.
Earlier call summaries
All →
15:46 IST
BSE
Earnings Call
Krishna Institute of Medical Sciences Earnings Call Transcript: Key Takeaways
KIMS delivered strong EBITDA margins despite lower ARPOB compared to peers, driven by lean operational efficiency and high patient volumes.
14:39 IST
BSE
Earnings Call
Krishna Institute of Medical Sciences Earnings Call: Key Takeaways
KIMS Hospitals Q4 FY26 earnings call highlighting robust 35.3% revenue growth to INR 1,084cr, despite EBITDA margin contraction to 19.9% due to heavy expansion and new unit drags.
13:33 IST
NSE
Earnings Call
Krishna Institute of Medical Sciences Earnings Call: Key Takeaways
KIMS delivered FY26 revenue growth of 28.2% YoY, reaching ₹39,308 Mn. Expansion continues across Telangana, AP, Maharashtra, and Kerala with a vision to reach 8600+ beds.
Krishna Institute Of Medical Sciences Ltd: key numbers
- Share price
- ₹732.35
- Market cap
- ₹30,759 Cr
- Revenue (annual)
- ₹3,905 Cr
- Net profit (annual)
- ₹241.4 Cr
- P/E (TTM)
- 144.8×Sector 54.5×
- Promoter holding
- 32.66%+0.16% QoQ
- FII holding
- 15.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.